BERTOZZI, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 159
EU - Europa 124
AS - Asia 84
AF - Africa 8
Totale 375
Nazione #
US - Stati Uniti d'America 159
CN - Cina 35
GB - Regno Unito 32
VN - Vietnam 24
UA - Ucraina 19
DE - Germania 18
IT - Italia 16
SG - Singapore 14
SE - Svezia 13
IN - India 7
IE - Irlanda 6
FR - Francia 5
RU - Federazione Russa 5
BG - Bulgaria 4
CI - Costa d'Avorio 4
EE - Estonia 4
JO - Giordania 3
CH - Svizzera 2
SC - Seychelles 2
ZA - Sudafrica 2
PK - Pakistan 1
Totale 375
Città #
Southend 28
Dong Ket 24
Fairfield 21
Singapore 13
Chandler 12
Jacksonville 12
Ashburn 11
Santa Clara 9
Princeton 8
Bologna 7
Wilmington 7
Cambridge 6
Dublin 6
Nanjing 6
Seattle 6
Woodbridge 6
Ann Arbor 5
Houston 5
Jinan 5
Abidjan 4
Berlin 4
Boardman 4
Padova 4
Shenyang 4
Sofia 4
Westminster 4
Amman 3
Beijing 3
Des Moines 3
Mülheim 3
Dearborn 2
Hebei 2
Lanzhou 2
Mahé 2
Medford 2
Nanchang 2
Taranto 2
Bern 1
Frankfurt Am Main 1
Fuzhou 1
Guangzhou 1
Jiaxing 1
Langfang 1
Los Angeles 1
Mardan 1
Napoli 1
Norwalk 1
Qingdao 1
Saint Petersburg 1
San Diego 1
Shenzhen 1
Taiyuan 1
Wuhan 1
Yuncheng 1
Totale 268
Nome #
A long antisense RNA is transcribed at the 5’ end of the human HIF-1a gene upon drug inhibition of DNA Topoisomerase I. 117
DNA topoisomerase I inhibition by camptothecin induces escape of RNA polymerase II from promoter-proximal pause site, antisense transcription and histone acetylation at the human HIF-1a gene locus. 92
The Natural Inhibitor of DNA Topoisomerase I, Camptothecin, Modulates HIF-1 alpha Activity by Changing miR Expression Patterns in Human Cancer Cells 86
Induction of a novel long antisense RNA from the human HIF-1a locus may contribuite to HIF 1a regulation and inhibition by campotecin in cancer cells. 82
Totale 377
Categoria #
all - tutte 965
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 965


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202069 0 0 0 0 7 10 9 8 18 7 3 7
2020/202149 12 2 1 4 0 4 1 2 3 2 2 16
2021/202259 15 2 0 2 5 6 0 5 2 1 11 10
2022/202370 5 9 3 7 4 3 2 3 20 3 5 6
2023/202423 2 5 2 3 2 5 0 1 0 0 2 1
2024/202538 5 8 6 2 17 0 0 0 0 0 0 0
Totale 377